Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025

NCT02004392 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

348

Enrollment

INDUSTRY

Sponsor class

Stopped Study has been suspended due to clinical hold.

Conditions

Alzheimer's Disease
Dementia

Interventions

DRUG: EVP-6124

Sponsor

FORUM Pharmaceuticals Inc